Literature DB >> 11349815

An ab initio theoretical study of the stereoisomers of tetrahydrocannabinols.

M J Huang1, J Leszczynski.   

Abstract

An extensive theoretical study of the stereoisomers of tetrahydrocannabinols has been performed at the ab initio HF/6-31G* and B3LYP/6-31G* levels. Effects of solvation were calculated with the Onsager model (with full geometry optimization), SCRF with Tomasi's PCM, and isodensity polarization continuum models. Single-point MP2//HF/6-31G* calculations were carried out. Frequency calculations for all the isomers at the HF/6-31G* level and for two natural isomers delta1-THC-RR and delta6-THC-RR at the B3LYP/6-31G* level were performed. Our results support the findings of the previous AM1 studies that the orientation of the carbocyclic ring and its C1 substituent with respect to the phenyl group hydroxyl oxygen play the major role in the activity. The calculated values of the LUMO energy (lowest unoccupied molecular orbital) and the hardness of the stereoisomers show that for the trans isomers it is easier to remove one electron from its HOMO (highest occupied molecular orbital) to the LUMO and easier to accept an electron from the receptor binding site than for the cis isomers. Combining geometric features (the orientation of the carbocyclic ring and its C1 substituent with respect to the phenyl group hydroxyl oxygen) with electronic features (LUMO and hardness), we explain the activity differences among the stereoisomers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11349815     DOI: 10.1023/a:1011187218375

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  19 in total

Review 1.  Recent advances in the chemistry of hashish.

Authors:  R Mechoulam; Y Gaoni
Journal:  Fortschr Chem Org Naturst       Date:  1967

2.  Structural studies of cannabinoids. A theoretical and proton magnetic resonance analysis.

Authors:  R A Archer; D B Boyd; P V Demarco; I J Tyminski; N L Allinger
Journal:  J Am Chem Soc       Date:  1970-08-26       Impact factor: 15.419

3.  Behavioral comparisons of the stereoisomers of tetrahydrocannabinols.

Authors:  B R Martin; R L Balster; R K Razdan; L S Harris; W L Dewey
Journal:  Life Sci       Date:  1981-08-10       Impact factor: 5.037

4.  The importance of the orientation of the C9 substituent to cannabinoid activity.

Authors:  P H Reggio; K V Greer; S M Cox
Journal:  J Med Chem       Date:  1989-07       Impact factor: 7.446

5.  Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency.

Authors:  B F Thomas; D R Compton; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  1990-11       Impact factor: 4.030

6.  Determination and characterization of a cannabinoid receptor in rat brain.

Authors:  W A Devane; F A Dysarz; M R Johnson; L S Melvin; A C Howlett
Journal:  Mol Pharmacol       Date:  1988-11       Impact factor: 4.436

7.  Molecular characterization of a peripheral receptor for cannabinoids.

Authors:  S Munro; K L Thomas; M Abu-Shaar
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

8.  Modeling the cannabinoid receptor: a three-dimensional quantitative structure-activity analysis.

Authors:  B F Thomas; D R Compton; B R Martin; S F Semus
Journal:  Mol Pharmacol       Date:  1991-11       Impact factor: 4.436

9.  Cannabidiol and phenytoin: a structural comparison.

Authors:  I Tamir; R Mechoulam; A Y Meyer
Journal:  J Med Chem       Date:  1980-02       Impact factor: 7.446

10.  Characterization of a region of steric interference at the cannabinoid receptor using the active analog approach.

Authors:  P H Reggio; A M Panu; S Miles
Journal:  J Med Chem       Date:  1993-06-11       Impact factor: 7.446

View more
  1 in total

1.  Reparameterized Austin Model 1 for quantitative structure-property relationships in liquid media.

Authors:  Dimitar A Dobchev; Mati Karelson
Journal:  J Mol Model       Date:  2006-01-11       Impact factor: 1.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.